Redefining Recovery Through Voice

We’re thrilled to partner with ElevenLabs, a leader in AI voice technology, to pilot a groundbreaking initiative for stroke survivors: the opportunity to create and reclaim a voice that reflects who they are – on the inside and out. Through this partnership, stroke survivors can access a free, five-year license to create a personalized AI voice.

What is ElevenLabs?

ElevenLabs is an advanced AI platform that creates realistic, customizable voices. Their voice cloning tools allow users to generate speech that sounds natural and uniquely personal.

Why Voice Matters

After stroke, many people experience changes in their speech that impact how they express themselves, connect with others, and feel seen. For some, it’s the loss of fluent speech. For others, it’s the unfamiliar sound of a changed voice.

Our identities are deeply intertwined with how we sound. This partnership aims to support emotional healing and identity rebuilding by giving survivors the chance to generate an AI voice that feels more like them.

Beta Test: Fall 2025

This fall, we’re running a limited beta test with a small group of SOCC members to:

  • Test ElevenLabs’ voice cloning tools
  • Explore the emotional impact of voice recovery
  • Build a toolkit to support the use of this technology in the stroke recovery journey

This pilot is designed for survivors who have experienced significant speech changes after stroke and are curious about how voice AI could support their recovery.

Their journeys — including the challenges, breakthroughs, and emotions they experience along the way — will be documented. These stories will serve as inspiration and step-by-step guidance for everyone when the full program launches in 2026.

Early Access Is Open

You can request a license code now and start exploring on your own.

Please note: We are still in our beta phase. Full onboarding resources, guidance, and community support will launch in early 2026 for Stroke Onward Community Circle (SOCC) members.

Until then, early access participants will be able to use their codes independently, while our selected beta testers receive additional support and help us shape the experience.

To request your code, email connect@strokeonward.org and we’ll send you a short questionnaire to fill out.

How It Works

1. Apply for a License

Complete our short intake form to confirm eligibility and request your free license code.

  • Must be 18 or older
  • Must be a stroke survivor with speech changes
  • Must provide the name of a doctor or clinic 

2. Receive Your Code

Eligible participants will receive a unique access code and setup instructions by email.
Each code provides one (1) year of access to ElevenLabs’ platform.

3. Create Your AI Voice

Use ElevenLabs’ easy-to-use platform to build a personalized voice from just a few minutes of recorded speech.

4. Join the Journey

In early 2026, you’ll gain access to new tutorials, community support, and events designed to help you get the most out of your voice

Frequently Asked Questions

Who is eligible to participate?

  • Adults (18+) who have experienced a stroke and are living with speech changes.
  • Participants must self-attest and provide the name of a doctor or clinic.

What’s the difference between early access and the beta test?

  • Beta testers are a small, selected group receiving support and participating in our video storytelling series.
  • Early access participants can apply now, use their codes independently, and will gain access to full support when the program officially launches in 2026.

How long does the license last?

  • Codes for stroke users who apply through Stroke Onward will be valid for five years and are renewable upon re-application. SLPs, AAC specialists, and other healthcare professionals will receive one-year codes.

Do I need to be a SOCC member to participate?

  • This program is being offered through SOCC. Joining SOCC is encouraged so you can access ongoing support and community.

What happens if I need help using ElevenLabs?

  • Support materials will be released in 2026 after the beta test. Until then, early access participants are self-guided.